Dr. Moopen’s Family Invests Rs 460 Cr, Raises Stake in Aster DM Healthcare by 4%
Key Points of Dr. Moopen’s Family Stake Raises in Aster DM Healthcare: Details of Dr. Moopen’s Family Stake Raises in…
PHARMA
Read More
Sun Pharma to Acquire 60% Stake in Vivaldis Health and Foods
Key Points of Sun Pharma Acquire Stake in Vivaldis Health and Foods: Details of Sun Pharma Acquire Stake in Vivaldis…
Eris Acquires 9 Dermatology Brands from Dr. Reddy’s for ₹275 Cr
Key Points of Eric Acquisition of Dr. Reddy’s Dermatology Brands: Details of Eric Acquisition of Dr. Reddy’s Dermatology Brands: Indian…
USFDA grants generic antibiotic medication from Glenmark Pharma approval
The US health authorities has given Glenmark Pharmaceuticals permission to market a generic antibiotic medicine, the company announced on Tuesday….
Pfizer acquires Seagen for $43B in Billion-Dollar deal
Pfizer Strikes $43 Billion Deal with Seagen to Expand Cancer Treatments Portfolio Pfizer Inc, the renowned drugmaker, has announced a…
Zydus gets final USFDA nod for Olanzapine Orally Disintegrating Tablets
Zydus Lifesciences Gets USFDA Approval to Market Olanzapine Orally Disintegrating Tablets Zydus Lifesciences, a leading global pharmaceutical company, has received…
Marksans Pharma gets USFDA nod for acid reflux tablets ANDA
Marksans Pharma Secures USFDA Approval for Famotidine Tablets Marksans Pharma announced on Friday that the United States Food and Drug…
Ajanta Pharma share buyback: price & key details to know
Ajanta Pharma Approves Buyback of Shares Worth ₹315 Crore Pharmaceutical company Ajanta Pharma’s board has approved a share buyback proposal…
Ajanta Pharma okays Rs 315 Cr share buyback at Rs 1,425 via tender
Key Points of Share Buyback: Details of Share Buyback: Ajanta Pharma Announces Third Share Buyback in Three Years On Friday,…
Alembic Pharma gets USFDA tentative Nod for Brexpiprazole Tablets
Key Points of Nod: Details of Nod: Alembic Pharmaceuticals Limited has announced that the US Food & Drug Administration (USFDA)…